Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner

Abstract

Retinal pigmented epithelial (RPE) cell integrity is critical to the maintenance of retina functions and RPE cells do not proliferate in adults. The activation of RPE results in cell proliferation which may be associated with proliferative retinopathy and choroidal melanoma. Mitogen-activated protein kinase (MAPK) is believed to be a key participant in the response to mitogenic stimuli. We therefore investigated the involvement of the extracellular signal-regulated protein kinase (ERK) 1 and 2 during the induction of RPE cell proliferation. After foetal calf serum (FCS) stimulation activation of the Ras/Raf/ERK signalling pathway was detected by Western blotting and immunochemistry, with specific anti-phosphosignalling protein antibodies. Pharmacological and antisense (AS) oligonucleotide (ODN) strategies were used to analyse the signalling involved in FCS-induced RPE cell proliferation. Activation of the small G protein Ras and, to a lesser extent of Raf-1, the kinase directly downstream from Ras, was necessary to FCS-induced cell proliferation. MEK1/2 and ERK1/2 were activated during cell proliferation. Inhibition of MEK1/2 with UO 126 completely abolished ERK1/2 activation and reduced cell proliferation by 33–43%. ERK1/2 depletion by an AS ODN approach reduced cell proliferation by 27–33%, confirming the role of ERK1/2 in the FCS stimulation of RPE cells. We also investigated the role of PKA/cAMP, one of the major inhibitory pathways of ERK1/2. PKA blockade did not modify ERK1/2 activation or cell proliferation. In contrast, agents that increased cAMP concentration, abolished RPE proliferation, and MEK/ERK activation. Moreover, inhibition of the cAMP-activated small G protein Rap1, partially reversed the inhibitory effects of cAMP on cell proliferation and MEK/ERK activation. The requirement for Ras and ERK1/2, the lack of ERK1/2 regulation by PKA and the cAMP/Rap1 counter-regulatory pathway for ERK-mediated cell proliferation suggest complex regulation of signalling in RPE cells. These data may have important implications for the development of more selective models for retinal anti-proliferative therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Adachi M, Fukuda M, Nishida E . 1999 EMBO J. 18: 5347–5358

  • Adachi M, Fukuda M, Nishida E . 2000 J. Cell Biol. 148: 849–856

  • Bornfeldt KE, Krebs EG . 1999 Cell Signal. 11: 465–477

  • Bryckaert M, Guillonneau X, Hecquet C, Courtois Y, Mascarelli F . 2000 Oncogene 19: 4917–4929

  • Campbell S, Khosravi-Fas R, Rossman KL, Clark GJ, Der CJ . 1998 Oncogene 17: 1395–1414

  • Chiariello M, Marinissen MJ, Gutkind JS . 2001 Nat. Cell. Biol. 3: 581–586

  • Ciullo I, Diez-Roux G, DI-Domenico M, Migliaccio A, Avyedimento EV . 2000 Oncogene 20: 1186–1192

  • Cook SJ, McCormick F . 1993 Science 262: 1069–1072

  • Daum GI, Eisenmann-Tappe I, Fries HW, Toppmair J, Rapp UR . 1994 Trends Biochem. Sci. 19: 474–480

  • Davis R . 1995 Mol. Rep. Dev. 42: 459–467

  • Dhanasekavan U, Premkumar Reddy E . 1998 Oncogene 17: 1447–1455

  • Enzmann V, Faude F, Kohen L, Wiedemann P . 1998 Ophthalmic Res. 30: 189–194

  • Guillonneau X, Bryckaert M, Longo-Launey C, Courtois Y, Mascarelli F . 1998 J. Biol. Chem. 273: 22367–22373

  • Her JH, Wu J, Rall TB, Sturgill TW, Weber MJ . 1991 Nucleic Acids Res. 19: 37–43

  • Hu CD, Karija KI, Okada T, QI X, Song C, Kataoka T . 1999 J. Biol. Chem. 274: 48–51

  • Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, Cobb MH . 1998 Cell 93: 605–615

  • Kim S, Jee K, Kim D, Hoh H, Chung J . 2001 J. Biol. Chem. 276: 12864–12870

  • McKenzie FR, Pouyssegur J . 1996 J. Biol. Chem. 271: 13476–13483

  • Magnuson NS, Beck T, Vahidi H, Hahn H, Smola U, Rapp UR . 1994 Semin. Cancer Biol. 5: 247–253

  • Monia BP, Sasmor H, Johnston JF, Freier SM, Lesnick EA, Muller M, Geiger T, Altmann KH, Moser H, Fabbro D . 1996 Proc. Natl. Acad. Sci. 93: 15481–15484

  • Morrison DK, Cutler RE . 1997 Curr. Opin. Cell. Biol. 9: 174–179

  • Schmitt JM, Stork PJ . 2001 Mol. Cell Biol. 21: 3671–3683

  • Sevetson BR, Kong X, Lawrance JC . 1993 Proc. Natl. Acad. Sci. 90: 10305–10309

  • Valtink M, Engelmann K, Strauss O, Kruger R, Löliger C, Ventura A, Richard G . 1999 Graefes Arch. Clin. Exp. Ophthalmol. 237: 1001–1006

  • Zimmermann S, Moelling K . 1999 Science 286: 1741–1744

  • Zubilewicz A, Hecquet C, Jeanny JC, Soubrane G, Courtois Y, Mascarelli F . 2001a Oncogene 20: 1403–1413

  • Zubilewicz A, Hecquet C, Jeanny JC, Soubrane G, Courtois Y, Mascarelli F . 2001b Invest. Ophthalmol. Vis. Sci. 42: 488–496

Download references

Acknowledgements

Supported by a grant from the Association pour la Recherche sur le Cancer (F Mascarelli, contract numbers 9697 and 4474), the Ligue contre le Cancer (F Mascarelli, contract number 75/01-RS/63) and the Ministère de l'Education et de la Recherche (G Lefevre).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frederic Mascarelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hecquet, C., Lefevre, G., Valtink, M. et al. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner. Oncogene 21, 6101–6112 (2002). https://doi.org/10.1038/sj.onc.1205765

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205765

Keywords

This article is cited by

Search

Quick links